Telix boss rules out capital raising as shares soar

MELBOURNE: Telix Pharmaceuticals boss Christian Behrenbruch has ruled out a capital raising to ... read more

Mayne Pharma set to defer capital return to investors

MELBOURNE: Mayne Pharma will defer a $65.5m capital return to shareholders by at ... read more

Fisher & Paykel Healthcare shares soar on revenue guidance

AUCKLAND: Shares in Fisher & Paykel Healthcare rose sharply after the company forecast ... read more

Federal Court tough justice leaves investors in the dark

MELBOURNE: Two of the biggest legal actions launched against Australian companies in recent ... read more